Prostate cancer (PCa) is the second-leading cause of cancer death among men in the United States. 1 Since its approval by the FDA in 1986, 2 PSA tests have been used extensively worldwide for ...
A recent study suggests that patients with high-risk prostate cancer (PCa) in need of renal transplantation should receive cancer treatment before their transplants, as surgery and radiation treatment ...
Effect of inflammation on prostate cancer incidence and dutasteride efficacy in the Reduction by Dutasteride of Cancer Events (REDUCE) study. Background: PLCO is a large-scale, randomized study to ...
Observational data suggested that men with nonmetastatic prostate cancer lived longer if they followed a healthier lifestyle. A higher prostate cancer behavior score was associated with reductions in ...
Use of 5-alpha-reductase inhibitors lower the risk of pathologic progression. Both findings on biopsy also predict a lower odds of high-grade cancer. Prostate atrophy (PA) and chronic prostate ...
Exosomes participate in drug resistance, vascular remodeling, and antigen presentation. Exosomes not only impair the function of immune cells but also reshape the tumor microenvironment, thereby ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback